Shypd.aiThe largest open index of AI tools
BenevolentAI is an AI drug discovery platform that accelerates biopharma research and development. It leverages a knowledge graph and proprietary ontologies to support scientists in identifying ground-breaking discoveries.
Trending
About
BenevolentAI, formerly Proximagen, is a leading AI drug discovery platform dedicated to accelerating biopharma research and development. The platform utilizes advanced AI and machine learning to target complex decisions in R&D, providing life science intelligence at users' fingertips. Building on a decade of investment in its knowledge graph and proprietary ontologies, BenevolentAI supports scientists and executives in leveraging cutting-edge AI with confidence and precision. The company's philosophy centers on building technology in the service of science, bringing together unique cross-sections of science and technology teams to push AI and machine learning to new limits in the pursuit of new medicines for hard-to-treat diseases.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check benevolent.ai for current pricing.
FAQs
Trending
